首页/数据集/Heterogeneous Response to Spesolimab in Pyoderma Gangrenosum Depends on Underlying Myeloid Disorders-supplymentary files

Heterogeneous Response to Spesolimab in Pyoderma Gangrenosum Depends on Underlying Myeloid Disorders-supplymentary files

Mendeley Data2026-04-09 收录

坏疽性脓皮病治疗

药物反应异质性

数据链接：

https://data.mendeley.com/datasets/js6jd98k43/1 数据链接链接失效反馈

官方服务：

资源简介：

supplymentary files for brief report "Heterogeneous Response to Spesolimab in Pyoderma Gangrenosum Depends on Underlying Myeloid Disorders"

应用场景：

相关数据集

Methotrexate for PG: Supplemental Table

医学研究

坏疽性脓皮病治疗

Supplemental Table for the article, "Methotrexate for pyoderma gangrenosum: a retrospective case series of 33 patients" by Josiah A. Williams, MD; Matthew L. Hrin, MD; Nathan L. Bowers, MD, PhD; Josep

Mendeley Data2024-01-31 更新160

Heterogeneity in the physiological states and pharmacological responses of differentiating 3T3-L1 preadipocytes

脂肪细胞分化

药物反应异质性

Immunofluorescence image showing 3T3-L1 preadipocytes fixed after 6 days of differentiation. Adiponectin and lipid droplets started to appear on small numbers of cells.

NIAID Data Ecosystem70

Methotrexate for PG: Supplemental Table

坏疽性脓皮病治疗

甲氨蝶呤疗效评估

Mendeley Data50

Phenotype-based probabilistic analysis of heterogeneous responses to cancer drugs and their combination efficacy

癌症治疗

药物反应异质性

Cell-to-cell variability generates subpopulations of drug-tolerant cells that diminish the efficacy of cancer drugs. Efficacious combination therapies are thus needed to block drug-tolerant cells via

NIAID Data Ecosystem90

Supplementary Material for: Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)

慢性透析贫血治疗

药物反应异质性

Introduction: Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) affects 10–15% of the chronic dialysis population. We explored baseline characteristics and predictors of ESA hyporesponsi

NIAID Data Ecosystem70